BERTHELSEN SPENCER R 4
4 · IONIS PHARMACEUTICALS INC · Filed Jun 20, 2024
Insider Transaction Report
Form 4
BERTHELSEN SPENCER R
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-06-17−16,000→ 0 totalExercise: $35.53From: 2015-07-01Exp: 2024-06-30→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2024-06-17$35.53/sh+16,000$568,480→ 163,257 total - Sale
Common Stock
2024-06-17$40.29/sh−16,000$644,640→ 147,257 total
Holdings
- 70(indirect: by Daughter)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.